Sonata Capital Group’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
CL
Sonata Capital Group's IBDX Position: Q3 2026 in Review
Sonata Capital Group increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 0.57% in Q3 2026, buying an estimated $5.37K and bringing the position to 38,572 shares worth $928K. The position accounts for 0.3% of the portfolio, ranked #62.
Sonata Capital Group first reported a position in IBDX in Q2 2025 and has held it in 6 quarters since. The position peaked at $966K in Q2 2026. 168 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.
- Sonata Capital Group held 38,572 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $928K as of Q3 2026.
- Sonata Capital Group bought 217 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $5.37K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.3% of Sonata Capital Group's portfolio in Q3 2026, its #62 holding.
- Sonata Capital Group first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 6 quarters since.
- Sonata Capital Group's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $966K in Q2 2026.
- 168 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.
Based on Sonata Capital Group's 13F filing for Q3 2026, filed 19 Oct 2026.